Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prostaglandin E1 reduces the keratinocyte toxicity of sorafenib by maintaining signal transducer and activator of transcription 3 (STAT3) activity and enhancing the cAMP response element binding protein (CREB) activity.
Shichiri H, Yamamoto K, Tokura M, Ishida T, Uda A, Bito T, Nishigori C, Nakagawa T, Hirano T, Yano I, Hirai M. Shichiri H, et al. Among authors: yano i. Biochem Biophys Res Commun. 2017 Apr 1;485(2):227-233. doi: 10.1016/j.bbrc.2017.02.107. Epub 2017 Feb 24. Biochem Biophys Res Commun. 2017. PMID: 28237700
Association of Single Nucleotide Polymorphisms in STAT3, ABCB1, and ABCG2 with Stomatitis in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Analysis in Japanese Patients.
Watanabe A, Yamamoto K, Ioroi T, Hirata S, Harada K, Miyake H, Fujisawa M, Nakagawa T, Yano I, Hirai M. Watanabe A, et al. Among authors: yano i. Biol Pharm Bull. 2017;40(4):458-464. doi: 10.1248/bpb.b16-00875. Biol Pharm Bull. 2017. PMID: 28381801 Free article.
Safety and Efficacy of Bis-Glyceryl Ascorbate (Amitose DGA) to Prevent Hand-Foot Skin Reaction in Patients With Renal Cell Carcinoma Receiving Sunitinib Therapy: Protocol for a Phase I/II, Uncontrolled, Single-Arm, Open-Label Trial.
Yamamoto K, Ioroi T, Harada K, Nishiyama S, Nishigori C, Yano I. Yamamoto K, et al. Among authors: yano i. JMIR Res Protoc. 2019 Aug 12;8(8):e14636. doi: 10.2196/14636. JMIR Res Protoc. 2019. PMID: 31407671 Free PMC article.
Efficacy of pharmacists’ assessment and intervention based on Screening Tool for Older Persons’ Appropriate Prescriptions for Japanese compared with Screening Tool of Older Persons' potentially inappropriate Prescriptions criteria version 2 in older patients with cardiovascular disease.
Kimura T, Ogura F, Kukita Y, Takahashi T, Yamamoto K, Ioroi T, Yano I. Kimura T, et al. Among authors: yano i. Geriatr Gerontol Int. 2019 Nov;19(11):1101-1107. doi: 10.1111/ggi.13773. Geriatr Gerontol Int. 2019. PMID: 31746526
427 results